if Bravura are not in this Vanguard tender, the market would be heavily disappointed I can imagine and perhaps perceived as the tech not having the competitive edge against its competitors meaning it will lose its shine with institutional investors
- Forums
- ASX - By Stock
- Ann: Change in substantial holding
BVS
bravura solutions limited.
Add to My Watchlist
0.00%
!
$2.23

if Bravura are not in this Vanguard tender, the market would be...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.23 |
Change
0.000(0.00%) |
Mkt cap ! $999.8M |
Open | High | Low | Value | Volume |
$2.22 | $2.25 | $2.19 | $462.7K | 209.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 27652 | $2.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.23 | 11003 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 27608 | 2.220 |
9 | 16801 | 2.210 |
11 | 45176 | 2.200 |
9 | 54548 | 2.190 |
8 | 141638 | 2.180 |
Price($) | Vol. | No. |
---|---|---|
2.230 | 10321 | 25 |
2.240 | 28602 | 17 |
2.250 | 41846 | 8 |
2.260 | 25989 | 9 |
2.270 | 142026 | 4 |
Last trade - 11.50am 19/06/2025 (20 minute delay) ? |
Featured News
BVS (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online